BMS, Novartis and Roche Score New Approvals for Key Drugs
Felicia Rodriguez
May 31, 2022
Published: May 31, 2022 By Vanessa Doctor, RN VIA: https://www.biospace.com/article/bristol-myers-squibb-novartis-and-roche-cancer-drugs-get-fda-nod/ The long weekend saw three established drugs developed by Bristol Myers Squibb, Novartis and Roche score new approvals from the U.S. Food and Drug Administration. Opdivo Now a First-Line Therapy for Esophageal Squamous Cell Carcinoma